Expression of the RNase III Enzyme DROSHA Is Reduced During Progression of Human Cutaneous Melanoma

Modern Pathology - United Kingdom
doi 10.1038/modpathol.2012.225
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

DLC1 Expression Is Reduced in Human Cutaneous Melanoma and Correlates With Patient Survival

Modern Pathology
Forensic MedicinePathology
2014English

DistinctMHCgene Expression Patterns During Progression of Melanoma

Genes Chromosomes and Cancer
Cancer ResearchGenetics
2009English

Erratum To: Progression of Cutaneous Melanoma: Implications for Treatment

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2012English

Expression of the Soluble Vascular Endothelial Growth Factor Receptor-1 in Cutaneous Melanoma: Role in Tumour Progression

British Journal of Dermatology
DermatologyMedicine
2011English

WNT5A Expression Increases During Melanoma Progression and Correlates With Outcome

Clinical Cancer Research
Cancer ResearchOncology
2008English

Dystroglycan Expression Is Frequently Reduced in Human Breast and Colon Cancers and Is Associated With Tumor Progression

American Journal of Pathology
Forensic MedicinePathology
2003English

Interleukin-6 Dependent Induction of the Cyclin Dependent Kinase Inhibitor P21WAF1/Cip1 Is Lost During Progression of Human Malignant Melanoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Loss of Nonclassical MHC Molecules MIC-A/B Expression During Progression of Uveal Melanoma

British Journal of Cancer
Cancer ResearchOncology
2004English

Dual Function of WNTS in Human Cutaneous Melanoma

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy